U.S. drug regulator flags data integrity, maintenance lapses at Dabur India plant

· thehindu.com

FDA highlights data integrity and contamination risks at Dabur India's plant, following a January inspection revealing significant lapses.

The U.S. Food and Drug Administration has flagged data integrity, manufacturing and maintenance lapses at one of Dabur India’s plants following an inspection ...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI